Schwartz Investment Counsel’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Hold |
1,000
| – | – | 0.01% | 109 |
|
|
2025
Q1 | $485K | Hold |
1,000
| – | – | 0.02% | 111 |
|
|
2024
Q4 | $403K | Hold |
1,000
| – | – | 0.01% | 115 |
|
|
2024
Q3 | $465K | Hold |
1,000
| – | – | 0.02% | 115 |
|
|
2024
Q2 | $469K | Hold |
1,000
| – | – | 0.02% | 116 |
|
|
2024
Q1 | $418K | Hold |
1,000
| – | – | 0.02% | 126 |
|
|
2023
Q4 | $407K | Hold |
1,000
| – | – | 0.02% | 122 |
|
|
2023
Q3 | $348K | Sell |
1,000
-1,000
| -50% | -$348K | 0.01% | 125 |
|
|
2023
Q2 | $704K | Hold |
2,000
| – | – | 0.03% | 112 |
|
|
2023
Q1 | $630K | Hold |
2,000
| – | – | 0.03% | 116 |
|
|
2022
Q4 | $578K | Hold |
2,000
| – | – | 0.03% | 113 |
|
|
2022
Q3 | $579K | Hold |
2,000
| – | – | 0.03% | 108 |
|
|
2022
Q2 | $564K | Sell |
2,000
-250
| -11% | -$70.5K | 0.03% | 108 |
|
|
2022
Q1 | $587K | Hold |
2,250
| – | – | 0.02% | 113 |
|
|
2021
Q4 | $494K | Buy |
2,250
+550
| +32% | +$121K | 0.02% | 116 |
|
|
2021
Q3 | $308K | Buy |
1,700
+600
| +55% | +$109K | 0.01% | 122 |
|
|
2021
Q2 | $222K | Hold |
1,100
| – | – | 0.01% | 130 |
|
|
2021
Q1 | $236K | Buy |
+1,100
| New | +$236K | 0.01% | 125 |
|